About Us

History

Our Strategic Evolution

Establishment through persistent technical refinement and industrial-scale manufacturing capability, providing reliable chemical foundations for global markets.

500+ Projects Completed
100% Quality Verified
Inner Mongolia Eppen Biotech Co., Ltd.

Historical Milestones

2011–2013

Company Establishment

The company was registered and established with a registered capital of 1.4 billion yuan. Located in the Resource-Based City Economic Transformation and Development Experimental Zone of Yuanbaoshan District, Chifeng City, it covers an area of ​​approximately 3,000 mu.

2014–2017

Capacity Expansion

Achieving a core product matrix of "Lysine + Threonine + MSG," achieving a leading global market share.

2018–2024

Mature Development

Established as an autonomous region-level enterprise technology center, and added several new amino acid production patents.

2025–Present

High-Quality Development

Promoting technological upgrades such as expanding corn storage capacity and upgrading equipment in the MSG workshop; continuously developing high-value-added products such as medical amino acids and niche amino acids. Obtained further patents related to L-tryptophan production, further consolidating its technological barriers.

Leading Towards Industrial Future

We continue to optimize our manufacturing framework, integrating high-purity synthesis expertise with sustainable production protocols to drive global chemical supply excellence.

Partner With Us